Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02546232 | Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting | active not recruiting | Phase 2 | 196 | Oslo University HospitalOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT04166799 | Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients | active not recruiting | N/A | 216 | Sunnybrook Health Sciences CentreOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT05594498 | A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients | active not recruiting | N/A | 45 | Sunnybrook Health Sciences CentreOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT02616432 | Tomosynthesis Mammographic Imaging Screening Trial(TMISTLead-in) | active not recruiting | N/A | 3,065 | Sunnybrook Health Sciences CentreOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT06865131 | Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique | active not recruiting | N/A | 20 | Sunnybrook Health Sciences CentreOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT05251714 | CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer | active not recruiting | Phase 1 / Phase 2 | 44 | Treadwell Therapeutics, IncINDUSTRY | 1 | May 18, 2025 | clinicaltrials |
| NCT05409664 | Moving Forward Together 4(MFT4) | active not recruiting | N/A | 68 | University of South CarolinaOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT01247233 | Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Cancer(SHARE) | active not recruiting | N/A | 1,006 | UNICANCEROTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05463601 | Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer | active not recruiting | Phase 2 | 132 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT03562637 | Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC | active not recruiting | Phase 3 | 575 | OBI Pharma, IncINDUSTRY | 13 | May 9, 2025 | clinicaltrials |
| NCT05179824 | Tempus Priority Study: A Pan-tumor Observational Study | active not recruiting | — | 1,000 | Tempus AIINDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT06190600 | Supervised Physical Activity in Young Women With Early Breast Cancer During Neoadjuvant Chemotherpy(SPORTNATHy) | active not recruiting | N/A | 40 | The Greater Poland Cancer CentreOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT04081805 | LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)(EPMLARF) | active not recruiting | N/A | 195 | Federal University of São PauloOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT03161353 | Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.(PHERGain) | active not recruiting | Phase 2 | 377 | MedSIROTHER | 7 | Apr 23, 2025 | clinicaltrials |
| NCT03077191 | Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience(Ipomammella) | active not recruiting | — | 410 | IRCCS San RaffaeleOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT04125277 | The SONImage Study(SONImage) | active not recruiting | N/A | 100 | The Netherlands Cancer InstituteOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT06926335 | Oncological Safety of Oncoplastic Breast Surgery in Multicentric Breast Cancer | active not recruiting | — | 30 | Assiut UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06926088 | Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer(CAMELIA) | active not recruiting | — | 500 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT05969314 | To Check Safety of Ayurvedic Oral Cannabis in Breast and Head and Neck Cancer | active not recruiting | Phase 1 | 12 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2025 | clinicaltrials |
| NCT05914792 | Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery | active not recruiting | — | 49 | University of PittsburghOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT03168880 | A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer(TNBC) | active not recruiting | Phase 3 | 720 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 9, 2025 | clinicaltrials |
| NCT04445844 | INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study | active not recruiting | Phase 2 | 25 | Mridula George, MDOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT03252717 | Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)(BIORISE) | active not recruiting | N/A | 500 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04688697 | Prepectoral and Subpectoral Implant-based Breast Reconstruction | active not recruiting | N/A | 300 | Fudan UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT04711109 | Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation(BRCA-P) | active not recruiting | Phase 3 | 300 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT05816538 | The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks | active not recruiting | N/A | 100 | University of RijekaOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT05252988 | Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib(DIANER) | active not recruiting | Phase 2 | 177 | Spanish Breast Cancer Research GroupOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT03460067 | Omission of Radiation in Patients With Her-2 Positive Breast Cancer | active not recruiting | N/A | 12 | University of Kansas Medical CenterOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT04749862 | Cancer Surveillance and Support(CANVAS) | active not recruiting | — | 565 | University of LeedsOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT06898229 | Effect of Audiovisual Education on Breast Cancer | active not recruiting | N/A | 160 | Mehmet Akif Ersoy UniversityOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT02290782 | TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer(TARGIT-C) | active not recruiting | N/A | 387 | Universitätsmedizin MannheimOTHER | 2 | Mar 26, 2025 | clinicaltrials |
| NCT04296175 | Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)(CITRINE) | active not recruiting | Phase 3 | 808 | Fudan UniversityOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT04802876 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors(ACROPOLI) | active not recruiting | Phase 2 | 184 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06378294 | Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)(MACMA) | active not recruiting | — | 82 | University Hospital A CoruñaOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06347393 | Transgender and Gender Diverse Individuals Screening for Breast Cancer(GENESIS) | active not recruiting | N/A | 1,600 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT00999804 | Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy(HELEX) | active not recruiting | Phase 2 | 128 | Baylor Breast Care CenterOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT02547987 | Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer(CADENCE) | active not recruiting | Phase 2 | 25 | Mothaffar RimawiOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT05918133 | A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC | active not recruiting | Phase 1 / Phase 2 | 42 | Biotheus Inc.INDUSTRY | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06868758 | Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer | active not recruiting | — | 50 | Chongqing General HospitalOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06869759 | "Effectiveness of Community Health Workers in Breast Cancer Prevention in Jumla: a Cluster Randomized Trials | active not recruiting | N/A | 180 | Karnali Academy of Health SciencesOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06866093 | The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical.(Lifestyle) | active not recruiting | — | 112 | National Cancer Institute, NaplesOTHER | 1 | Mar 10, 2025 | clinicaltrials |
| NCT03324425 | Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer(SIMPHONY) | active not recruiting | Phase 2 | 5 | Baylor Breast Care CenterOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT04807192 | CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC) | active not recruiting | Phase 2 | 40 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT03944434 | FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer(FACILE) | active not recruiting | Phase 2 | 116 | Fondazione Sandro PitiglianiOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT02625441 | Adjuvant Trastuzumab, Pertuzumab Plus Docetaxel in the Treatment of Early HER2-positive Breast Cancer(BOLD-1) | active not recruiting | Phase 3 | 516 | Helsinki University Central HospitalOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT05663294 | PBI for Breast in Situ Carcinoma of Intermediate Low Risk As Local Adjuvant Treatment(PRISCILLA) | active not recruiting | N/A | 150 | Istituto Clinico HumanitasOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT06805084 | Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas(H/ACA-ER) | active not recruiting | — | 80 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT01644669 | Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System® | active not recruiting | N/A | 1,200 | Xoft, Inc.INDUSTRY | 3 | Jan 31, 2025 | clinicaltrials |
| NCT00248287 | PhII ICb With/Without Erbitux in MBC Pts(CA225200) | active not recruiting | Phase 2 | 154 | US Oncology ResearchINDUSTRY | 1 | Jan 29, 2025 | clinicaltrials |
| NCT02752685 | Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer | active not recruiting | Phase 2 | 70 | NYU Langone HealthOTHER | 1 | Jan 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jun 4, 2025source: clinicaltrials